| Vial description: |
purified Insulin Receptor beta Positive Control |
| Antibody's or peptide concentration: |
ug/ml in stabilization buffer |
| Raised in: |
sterile environment |
| Reactivity: |
specific antigen |
| Immunogen: |
see msds |
| Antigen or peptide: |
Insulin Receptor beta |
| Original name: |
Insulin Receptor beta Positive Control |
| Phosphorylation: |
Non phosphorylated |
| Epitope: |
specific sequence |
| Type: |
Positive Control |
| Antibody's relevance: |
WB |
| Antibody's application: |
Western Blot |
| Storage conditions: |
-20⁰C for long term storage |
| Genbank number: |
see ncbi |
| Protein number: |
P06213 |
| Test: |
PVDF is more advised, The best detection method is using enhanced chemiluminescence or ECL, Western Blot can be performed on tissues and cell extracts to determine the proteins present in your sample after PAGE electrophoresis and transfer on PVDF or Nitrocellulose |
| Description: |
Positive controls are the same as the target vector or antibody or protein and can be spiked to the sample before the analysis starts |
| Group: |
positif |
| Gene target: |
Insulin Receptor beta Controlfor |
| Short name: |
Insulin Receptor beta Positive Controlfor Blot |
| Technique: |
western Blots, Western Blot |
| Alternative name: |
Insulin Receptor b Positive Controlfor Western Blot |
| Alternative technique: |
controls |